MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5152/j.aott.2024.23132

Медицинская библиотека · Acta orthopaedica et traumatologica turcica · 2024

Prognostic factors and real-life applicability of prognostic models for patients with bone metastases of carcinoma.

Dalkir Kaan Ali, Mirioglu Akif, Kundakci Bugra, Bagir Melih, Deveci Mehmet Ali, Ozberlas Hilmi Serdar

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

This study aimed to investigate the factors affecting the survival of patients with bone carcinoma metastases and assess the clinical applicability of existing prognostic models.

METHODS

We retrospectively evaluated 247 patients who presented to our hospital between 2011 and 2021 diagnosed with bone carcinoma metastasis. Demographic data, general health status, primary diagnoses, laboratory and radiological findings, pathological fracture status, treatment methods, and survival times of the patients were recorded, and the effects of these variables on survival time were evaluated. Previously developed Katagiri, Janssen, 2013-Spring, PathFX, and SORG prognostic models were applied, and the predictive performances of these models were evaluated by comparing the predicted survival time with the actual survival time of our patients.

RESULTS

After the multivariate analysis, the following factors were shown to be significantly associated with the survival time of patients: blood hemoglobin and leukocyte levels, lactate dehydrogenase concentration, prognostic nutritional index, body mass index, performance status, medium and fast-growing groups of primary tumors, presence of extraspinal and visceral or brain metastases, and pathological fractures. According to receiver operating characteristics and Brier scores, SORG had the overall highest performance scores, while the Janssen nomogram had the lowest.

CONCLUSION

Our report showed that all prognostic models were clinically applicable, but their performances varied. Among them, the SORG predictive model had the best performance scores overall and is the model the authors suggested for survival prediction among patients with carcinoma bone metastases.

LEVEL OF EVIDENCE: Level IV, Prognostic Study.

Для цитирования: Dalkir Kaan Ali, Mirioglu Akif, Kundakci Bugra, Bagir Melih, Deveci Mehmet Ali, Ozberlas Hilmi Serdar. Prognostic factors and real-life applicability of prognostic models for patients with bone metastases of carcinoma.. Acta orthopaedica et traumatologica turcica. 2024. DOI: 10.5152/j.aott.2024.23132.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.